Newsletter Subject

Lifestyle-Dementia Links Persist Regardless of Risk Genes, French Study Shows

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Thu, May 23, 2024 10:47 PM

Email Preheader Text

Daily Headlines Thursday, May 23, 2024 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT T

[MEDPAGE TODAY]( Daily Headlines Thursday, May 23, 2024 Today's Top Stories for {NAME} [NEUROLOGY]( [Lifestyle-Dementia Links Persist Regardless of Risk Genes, French Study Shows]( [PSYCHIATRY]( [Can Mental Disorders Be Transmitted Among Teen Peer Networks?]( [PEDIATRICS]( [Prenatal Fluoride Exposure Linked to Neurobehavioral Problems]( THE BREAK ROOM [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Uncovering the Under-Diagnosed in MDS: The MDS Diagnostic Accelerator Hub]( [PRACTICE MANAGEMENT]( [More Money, Fewer Prior Auths Needed to Save Private Practices, Lawmakers Told]( [EMERGENCY MEDICINE]( [Chest Pain in the ED: More Referrals for Cardiac Tests Not Tied to Better Outcomes]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [OB/GYN]( [Louisiana Lawmakers Vote to Classify Abortion Pills as Controlled Dangerous Drugs]( CME SPOTLIGHT [Navigating CAR T-Cell Therapy for Non-Hodgkin Lymphoma in Community Practice]( [MEETING COVERAGE]( [Blood-Based Test for CRC Screening Hits Sensitivity, Specificity Endpoints]( [NEPHROLOGY]( [Outcomes OK With Transplant of Previously Dialyzed Kidneys]( [POP MEDICINE]( ['Fully Conscious Baby'; Anaphylaxis While Scuba Diving? Bridgerton's Body Positivity]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Unmasking von Hippel-Lindau (VHL) Disease: A Challenge in Clinical Recognition and Diagnosis]( [MEETING COVERAGE]( [Inhaled Amikacin Shows Promise for Untreated MAC Lung Infections]( [MEETING COVERAGE]( [GLP-2 Analog Reduces Need for Parenteral Support in Patients With Rare GI Condition]( [INFECTIOUS DISEASE]( [CDC: Less Than 1% of Mpox Cases Occurred After Two Doses of Jynneos Vaccine]( CME SPOTLIGHT [Integrating Novel Bispecific Antibody Therapies Into Treatment Paradigms in Relapsed/Refractory Follicular Lymphoma]( [PERSPECTIVES]( [Is $10 the Best BetterHelp Could Do for Violating Patient Privacy?]( [PUBLIC HEALTH & POLICY]( [Can Medicare Money Protect Doctors From Abortion Crimes? It Has Worked Before.]( [OPHTHALMOLOGY]( [Daily Low-Dose Aspirin Fails to Prevent AMD in Older Adults]( CME SPOTLIGHT [Mastering Mast Cell Mysteries: A Clinical Case Challenge in Recognizing and Managing Indolent Systemic Mastocytosis]( [PEDIATRICS]( [Ultraprocessed Food Consumption in Young Kids Tied to Cardiometabolic Risk Factors]( [SPECIAL REPORTS]( [Doc Wins $14M Discrimination Case; $10M Malpractice Award; Nurse Impersonators]( [INFECTIOUS DISEASE]( [Middle School HPV Vaccination Program Boosted Uptake]( CME SPOTLIGHT [Latest Evidence for Treating Secondary AML]( [AAD READING ROOM]( [What's in a Name? For Steroid Treatment in Atopic Dermatitis, Wording Makes a Big Difference]( Industry Clinic AD INSIGHTS [Recognizing Racial Disparities Impacting Rare Kidney Disease Patients]( # Weekly Survey [What's Your Telehealth Background?]( A recent survey found that patients prefer doctors to conduct their telehealth appointments [from their office or an exam room](, instead of their kitchen or bedroom[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2024-05-23&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.